Actinium Pharmaceuticals, Inc. (ATNM) › Weighted Average Diluted SharesActinium Pharmaceuticals, Inc. (ATNM) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2021-12-31: 20.57M2022-12-31: 24.14M2023-12-31: 26.60M2024-12-31: 30.07M2025-12-31: 31.20M31.20M2021-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3131.20M+3.7%2026-03-30From 2025-01-012024-12-3130.07M+13.0%2026-03-30From 2024-01-012023-12-3126.60M+10.2%2025-03-31From 2023-01-012022-12-3124.14M+17.4%2024-03-29From 2022-01-012021-12-3120.57M—2023-03-31From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)